Novartis Czech Republic - Current Assets

Novartis Czech Republic`s Current Assets reached 1,770 CZK mil in 2017. This is 11.4 % more than in the previous year.

$1.99

Buy Current Assets data for Novartis Czech Republic.

$19.99

Buy all data for Novartis Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             219 253 213 263 274    
Bayer Czech Republic CZK mil ... ... ...                 698 539 678 662 810    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 3,084 2,321 2,295 1,959 2,066    
Merck Czech Republic CZK mil ... ...                   432 488 534 469 523    
Novartis Czech Republic CZK mil                       1,383 1,487 1,469 1,611 1,853    
Pfizer Czech Republic CZK mil ... ...                   2,866 2,518 2,798 2,818 1,737    
Roche Czech Republic CZK mil ... ... ...                 1,971 1,988 1,905 1,962 2,228   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               3,102 3,237 2,644 2,307 2,597    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 88.1 92.3 234 251    
Walmark CZK mil ... ... ...                 1,019 975 1,171 1,349 442